Areas of consensus at APCCC last year … see Table 1

So your sitemaster has been looking through the full report from the APCCC meeting held in Basel last year — as he promised he would. … READ MORE …

Detailed data from the APCCC meeting in Basel now available

Last August your sitemaster attended and reported from the third iteration of the Advanced Prostate Cancer Consensus Conference (APCCC), held in Basel, Switzerland (see here, here, and here). … READ MORE …

The APCCC in Basel, Switzerland: where to get the details

Our friends at UroToday are now making available the individual presenters’ slides and other materials from the 3rd Advanced Prostate Cancer Consensus Conference (APCCC) that ended in Basel, Switzerland, last Saturday, as well as detailed interviews on specific topics that were recorded at the meeting. … READ MORE …

The upcoming APCCC 2019 meeting on advanced prostate cancer

The first iteration of the Advanced Prostate Cancer Consensus Conference (APCCC) was held in St. Gallen, Switzerland, in 2017, and the second iteration is upcoming in late August this year — this time in Basel. … READ MORE …

Report from APCCC 2017 on management of advanced prostate cancer

For those who really want all the details, the full text of the report from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017 is now available on line. … READ MORE …

Finding common ground on how “best” to treat localized prostate cancer, and what to tell the patients

One of the hardest issues for newly diagnosed prostate cancer patients to deal with has long been the differences in opinion between physicians about appropriate first-line treatment (and the relevant information they are offered) — most especially for patients with localized disease. … READ MORE …

St. Gallen consensus conference on treatment of advanced prostate cancer

Apparently, early in 2015, there was a major international consensus conference, among nearly 50 of the leading international authorities, on the treatment of advanced prostate cancer. … READ MORE …